CTLA4 and neoplasm: Upregulation of immune checkpoints, such as CTLA-4, by regulatory T cells, Tregs, or PD-1/PD-L1 axis in the tumor microenvironment results in abrogation of effector T-cell function that compromises immune clearance of tumor clones.